According to Sorrento Therapeutics 's latest financial reports the company's current revenue (TTM ) is A$96.1 Million. In 2022 the company made a revenue of A$92.34 Million an increase over the revenue in the year 2021 that were of A$72.97 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.